Lilly obesity-pill trial results find a warmer reception on Wall Street this time around




Pharmaceutical giant Eli Lilly said it will now move “with urgency” toward getting regulatory approval for orforglipron.



Source link

More From Author

SUNSHINE & RAINBOWS – Atlantic-Pacific

The End-of-Summer Capsule: 12 Pieces I’m Wearing On Repeat

Leave a Reply

Your email address will not be published. Required fields are marked *